| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/17/2008 | WO2008023027A3 Process for preparing pramipexole dihydrochloride tablets with high storage stability |
| 04/17/2008 | WO2008021536A3 Use of interferon tau for the manufacture of a medicament in combination with interferon-alpha or interferon-beta for reduction of their adverse effects |
| 04/17/2008 | WO2008019109A3 Stabilization of lorazepam |
| 04/17/2008 | WO2008015203A3 Compositions of microparticles and granules for oral controlled release of substances for veterinary use |
| 04/17/2008 | WO2008009589A3 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 04/17/2008 | WO2008008139A3 Methods and devices for forming treatment agent carriers |
| 04/17/2008 | WO2008006912A3 Polymer |
| 04/17/2008 | WO2008005580A3 Formulation for treatment of acne |
| 04/17/2008 | WO2008002568A3 Active agent formulations, methods of making, and methods of use |
| 04/17/2008 | WO2008001184A3 Solid composition |
| 04/17/2008 | WO2007147371A3 Pharmaceutical composition for oral administration |
| 04/17/2008 | WO2007146005A3 Sustained release oxycodone composition with acrylic polymer and metal hydroxide |
| 04/17/2008 | WO2007144084A3 Type-2 diabetes combination wafer |
| 04/17/2008 | WO2007144083A3 Ache-nmda combination wafer |
| 04/17/2008 | WO2007141667A3 Immunosuppressive extract of cordyceps sinensis and uses thereof |
| 04/17/2008 | WO2007140315A3 System and method for delivering an agglomeration of solid beads and cement to the interior of a bone in order to form an implant within the bone |
| 04/17/2008 | WO2007134845A3 Olanzapine pharmaceutical composition |
| 04/17/2008 | WO2007134158A3 Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy |
| 04/17/2008 | WO2007129162A3 Pharmaceutical preparations for transdermal use |
| 04/17/2008 | WO2007124869A3 Liquid pharmaceutical formulation |
| 04/17/2008 | WO2007124224A3 Method for delivering particulate drugs to tissues |
| 04/17/2008 | WO2007099410A3 Formulations of fispemifene |
| 04/17/2008 | WO2007099377A3 Cancer treatments |
| 04/17/2008 | WO2007095600A3 Disintegrable oral films |
| 04/17/2008 | WO2007092179A3 Device with nanocomposite coating for controlled drug release |
| 04/17/2008 | WO2007086911A3 Stable nanoparticle formulations |
| 04/17/2008 | WO2007052164A8 A pharmaceutical formulation containing olanzapine |
| 04/17/2008 | WO2007028341A8 Nano anticancer micelles of vinca alkaloids entrapped in polyethylene glycolylated phospholipids |
| 04/17/2008 | WO2007001658A3 Therapeutic pastes for medical device coating |
| 04/17/2008 | US20080091263 Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts |
| 04/17/2008 | US20080091176 Osmotic delivery systems and piston assemblies for use therein |
| 04/17/2008 | US20080091007 Modified cellulose films |
| 04/17/2008 | US20080090912 Compositions containing prodrugs of florfenicol and methods of use |
| 04/17/2008 | US20080090911 Storage stability; ethyl laurate and guar gum; alcohol free; topical administration; sexual disorders |
| 04/17/2008 | US20080090894 Transdermal migraine therapy |
| 04/17/2008 | US20080090754 A protein, e.g., insulin or a growth hormone; a polyol, e.g., mannitol or polyethylene glycol; zinc; stabilized against denaturing when in contact with an organic solvent |
| 04/17/2008 | US20080090753 Rapid Acting Injectable Insulin Compositions |
| 04/17/2008 | US20080089963 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 04/17/2008 | US20080089944 Method for precipitation of small medicament particles into use containers |
| 04/17/2008 | US20080089943 Use of adsorbent carbon microspheres to treat gastroesophogeal reflux disease |
| 04/17/2008 | US20080089942 Use of adsorbent carbon microspheres to treat intestinal bacterial infections |
| 04/17/2008 | US20080089941 Fucoidan compositions and methods |
| 04/17/2008 | US20080089940 Improved swelling, strength, ruggedness, and resiliency; controlled gastic release |
| 04/17/2008 | US20080089939 Dermastick thickened ointment |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089937 Controlled release drug compositions and preparation methods |
| 04/17/2008 | US20080089936 Prolonged release formulation of active principles having a ph-dependent solubility |
| 04/17/2008 | US20080089935 Stable Solid Dispersion Of A Derivative Of Vinca Alkaloid And Process For Manufacturing It |
| 04/17/2008 | US20080089934 Soft capsules, solid dosage forms; heating, hydrating, mixing, solubilizing a high solids, low moisture film-forming mixture to form a homogeneous molten composition, wherein said temperature is at or above the solubilizing temperature, feeding into pump, cooling; thermoreversible gel films |
| 04/17/2008 | US20080089933 Device and method for reducing calorie intake |
| 04/17/2008 | US20080089932 Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome |
| 04/17/2008 | US20080089931 EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders |
| 04/17/2008 | US20080089930 Keratin-Based Powders and Hydrogel for Pharmaceutical Applications |
| 04/17/2008 | US20080089929 Immunogenic fusion comprising transcription and negative factor domains for use in generation vaccine for prevention and treatment of viral infections; immunostimulants |
| 04/17/2008 | US20080089928 Liposome drug carriers with ph-sensitivity |
| 04/17/2008 | US20080089927 High drug to lipid ratio |
| 04/17/2008 | US20080089926 Formed of isoprene-styrene block copolymer; improved skin permeability and lower irritation |
| 04/17/2008 | US20080089921 Apparatus for piezoelectric layer-wise pump and valve for use in local administration of biological response modifiers and therapeutic agents |
| 04/17/2008 | US20080089920 Local infusion of tumor necrosis factors (TNF); implants; pharmacokinetics |
| 04/17/2008 | US20080089912 Intrathecal Injection of Microbubbles Containing a Thrombolytic Agent |
| 04/17/2008 | US20080089908 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/17/2008 | US20080089849 Powders for inhalation |
| 04/17/2008 | US20080089848 Intrathecal injection of microbubbles |
| 04/17/2008 | US20080089836 superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography |
| 04/17/2008 | US20080087293 Hair treatment application system |
| 04/17/2008 | DE202008001805U1 Handschuh zur Anregung der Blutzirkulation und zur Hautpflege Glove to stimulate blood circulation and skin care |
| 04/17/2008 | CA2702340A1 Compositions and methods for modulating immune responses |
| 04/17/2008 | CA2672686A1 Pharmaceutical formulations |
| 04/17/2008 | CA2666440A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 04/17/2008 | CA2666058A1 Aqueous liquid preparation comprising gatifloxacin |
| 04/17/2008 | CA2665764A1 Pharmaceutical anti-infective composition for inhalation |
| 04/17/2008 | CA2665604A1 Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers |
| 04/17/2008 | CA2665423A1 Methods and compositions with reduced opalescence |
| 04/17/2008 | CA2663805A1 Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory |
| 04/17/2008 | CA2652980A1 Robust sustained release formulations of oxymorphone |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911488A2 Device for enhancing transdermal agent flux |
| 04/16/2008 | EP1911463A1 Weight management system for obese animals |
| 04/16/2008 | EP1911462A2 Compositions comprising a sterol absorption inhibitor |
| 04/16/2008 | EP1911456A1 A medicine for abstaining from addiction to drugs and process thereof |
| 04/16/2008 | EP1911455A1 Topical vaginal pharmaceutical compositions |
| 04/16/2008 | EP1911445A2 Stable pharmaceutical formulation comprising an HMG-COA reductase inhibitor |
| 04/16/2008 | EP1911444A1 Drug-containing coated fine particle for intrabuccally disintegrating preparation and method of producing the same |
| 04/16/2008 | EP1911443A1 Amphoteric liposomes, method of formulating an amphoteric liposome and a method of loading an amphoteric liposome |
| 04/16/2008 | EP1911442A2 Preparation for the prevention and/or treatment of vascular disorders |
| 04/16/2008 | EP1911441A2 Controlled release color stable pharmaceutical dosage form of HMG-COA reductase inhibitors, free of alkalizing or buffering agents |
| 04/16/2008 | EP1910526A2 Methods for the administration of fv and related compositions |
| 04/16/2008 | EP1909841A2 Vaginal treatment composition |
| 04/16/2008 | EP1909840A1 Medicated gauze |
| 04/16/2008 | EP1909831A2 Self-buffering protein formulations |
| 04/16/2008 | EP1909827A2 The modulation of immunity and ceacam1 activity |
| 04/16/2008 | EP1909825A1 Stabilized parathyroid hormone composition comprising parathyroid hormone, buffer and stabilizing agent |
| 04/16/2008 | EP1909798A2 Oral suspension of prednisolone acetate |
| 04/16/2008 | EP1909793A2 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 04/16/2008 | EP1909773A1 Transdermal system for varenicline |
| 04/16/2008 | EP1909772A1 Transdermal drug delivery formulation |
| 04/16/2008 | EP1909771A1 Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same |
| 04/16/2008 | EP1909770A2 Oral controlled release composition containing levetiracetam |
| 04/16/2008 | EP1909769A2 Alcohol resistant pharmaceutical formulations |
| 04/16/2008 | EP1909768A1 Extended release solid pharmaceutical composition containing carbidopa and levodopa |